Thierry André

基本信息

Career Trajectory

Bio

He is/was a principal investigator of many phase 1, 2, and 3 clinical trials evaluating treatment of gastrointestinal malignancies. Prof André’s main research interest is gastrointestinal malignancies and especially the treatment of colorectal cancer and cancers harboring microsatellite instability / DNA mismatch repair deficiency. He has published 480 peer-reviewed articles (H index 93).

Research Interests

Papers共 1013 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Dmmr/msi Tumour Occurrence During Follow-Up of Patients with Lynch Syndrome Treated with Immune Checkpoint Inhibitors for a Metastatic Digestive Cancer Between 2015 and 2024: A Retrospective Monocentric Cohort

Anna Pellat, Camille Loisel,Antoine Dardenne,Thierry Andre

Journal of Clinical Oncologyno. 4_suppl (2025): 96-96

Cited0Views0Bibtex

Associations Between Early Tumor Shrinkage/depth of Response and Survival from the ARCAD Database

Hideaki Bando, Yuriko Takeda,Toshihiro Misumi, Tomomi Nishikawa,Masashi Wakabayashi,Kentaro Yamazaki,Eiji Oki, Jean-Yves Douillard,Cornelis J A Punt,Miriam Koopman,Eric Van Cutsem,Carsten Bokemeyer, Alan P Venook, Heinz-Josef Lenz, Yoshihiko Maehara,Thierry Andre,Qian Shi,Aimery de Gramont,Takayuki Yoshino

JNCI cancer spectrumno. 3 (2025)

Cited0Views0WOSBibtex

Biological and Therapeutic Impact of Tumor Mutational Burden in Microsatellite Instability/mismatch Repair-Deficient (msi/dmmr) Metastatic Colorectal Cancer (mcrc) Treated with Immune Checkpoint Inhibitors (ICI)

Sarah Blanchet Deverly, Balthazar Raffy,Toky Ratovomanana, Remy Nicolle, Paula Nay,Thierry Andre,Alex Duval,Romain Cohen

Journal of Clinical Oncologyno. 4_suppl (2025): 272-272

Cited0Views0Bibtex

Preliminary Results from a Randomized, Open-Label, Phase 2 Study of Botensilimab (BOT) with or Without Balstilimab (BAL) in Refractory Microsatellite Stable Metastatic Colorectal Cancer with No Liver Metastases (MSS Mcrc NLM)

Marwan Fakih,Neil Howard Segal,Benjamin L. Schlechter,Thierry Andre,Filippo Pietrantonio, Benny Johnson, Alexander Vasilyev,Smitha S. Krishnamurthi,Salvatore Siena,Wells A. Messersmith, Virgilio Souza E Silva,Andrew Scott Paulson,Elena Elez,Cathy Eng,Sabine Tejpar,Michel Pierre Ducreux, Wei Wu,Joseph Elan Grossman,Eric Van Cutsem,Manuel Hidalgo

Journal of Clinical Oncologyno. 4_suppl (2025): 23-23

Cited0Views0Bibtex

The METACER National Cohort Study of Brain Metastases in Gastrointestinal Cancers Prospectively Establishes Prognostic Factors

Violaine Randrian,Fabienne Portales,Olivier Bouché,Simon Thezenas,Benoist Chibaudel,May Mabro,Eric Terrebonne, Claire Garnier-Tixidre,Christophe Louvet,Thierry André,Thomas Aparicio,Olivier Dubreuil, Gregoire Bouché,Marc Ychou,David Tougeron

Journal of Neuro-Oncologypp.1-10, (2025)

Cited0Views0WOSBibtex

The Prognostic Nutritional Index in Patients with Microsatellite Instability-High Metastatic Gastric or Gastroesophageal Cancers Receiving Immune Checkpoint Inhibitors

Filippo Ghelardi,Giovanni Fuca,Chiara Cavalli,Kohei Shitara,Romain Cohen,Margherita Ambrosini,Steven B. Maron,Riccardo Cerantola,Vincenzo Nasca, Giorgia Di Liberti,Luca Zambelli,Michele Palazzo,Massimiliano Salati,Yu Aoki,Akihito Kawazoe,Darren Cowzer,Sara Lonardi,Thierry Andre,Giovanni Randon,Filippo Pietrantonio

DIGESTIVE AND LIVER DISEASEno. 1 (2025): 23-29

Cited0Views0WOSBibtex

A Phase Ia/b Study of MEK1/2 Inhibitor Binimetinib with MET Inhibitor Crizotinib in Patients with RAS Mutant Advanced Colorectal Cancer (Mercuric)

Francesca Aroldi,Elena Elez,Thierry André,Geraldine Perkins,Hans Prenen,Vlad Popovici, Peter Gallagher, Jennifer Houlden, Linda Collins,Corran Roberts,Christian Rolfo,Federica Di Nicolantonio, Margaret Grayson, Ruth Boyd, Karolien Bettens, Jurgen Delfavero,Victoria Coyle,Mark Lawler,Hajrah Khawaja, Pierre Laurent-Puig, Manuel Salto-Tellez, Tim S. Maughan,Josep Tabernero,Richard Adams,Robert Jones,Bryan T. Hennessy,Alberto Bardelli,Marc Peeters, Mark R. Middleton,Richard H. Wilson,Sandra Van Schaeybroeck

BMC Cancerno. 1 (2025): 1-15

Cited0Views0WOSBibtex

Pooled Safety Analysis of Two Phase 3 Studies Investigating Trifluridine/tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

Julien Taieb,Marwan Fakih,Gabor Liposits,Gerald W. Prager,Eric Van Cutsem,Fortunato Ciardiello,Nadia Amellal, Elizabeth Calleja,Mei Liu, Lucas Roby,Josep Tabernero,Thierry Andre

FRONTIERS IN ONCOLOGY (2025)

Cited0Views0WOSBibtex

Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post-Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials

Angélique Vienot,Dewi Vernerey,Adeline Bouard,Elodie Klajer,Stefano Kim,Christophe Tournigand,Christophe Louvet,Thierry André,Benoît Rousseau,Mylène Wespiser,Laurie Spehner,Ying A Wang,Anke Weispfenning, Emmanuelle Dochy,Christophe Borg

Cancer research communicationsno. 2 (2025): 287-294

Cited0Views0WOSBibtex

Interplay Between Sarcopenia, GDF-15, and the Efficacy of Nivolumab Plus Ipilimumab in Patients with Mismatch Repair Deficient Metastatic Colorectal Cancer: Final Survival Analysis of the Phase II GERCOR NIPICOL Study

Leonard Depotte, Paula Nay,Christophe Borg,Aurélia Meurisse, Julie Henriques,Jaafar Bennouna,Christelle De La Fouchardière,David Tougeron,Thibault Mazard,Benoist Chibaudel,Christophe Tournigand,Dewi Vernerey, Frédéric Pigneur,Thierry Andre,Romain Cohen

Journal for immunotherapy of cancer（2025）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 1013 篇Author StatisticsCo-AuthorSimilar Experts